STRM 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，若以價值投資為目標，已經有長期投資部位可能需陸續減碼
STRM 近期報酬表現
0.32%
Streamline health solutions, inc.
4.57%
同產業平均
0.12%
S&P500
與 STRM 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
HKIT | Hitek global inc | - | 2 分 | 3 分 | - | 1 分 | |
VYX | Ncr voyix corp | 3 分 | 3 分 | 2 分 | 3 分 | 1 分 | |
OBLG | Oblong inc | 4 分 | 5 分 | 2 分 | - | 1 分 | |
SPSC | Sps commerce, inc. | 5 分 | 4 分 | 4 分 | 3 分 | 1 分 | |
KVYO | Klaviyo inc | - | 3 分 | 2 分 | 1 分 | 1 分 |
- HKIT Hitek global inc價值 -趨勢 2 分波段 3 分籌碼 -股利 1 分查看更多
STRM 公司資訊
Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.